We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
State Senator Leah Vukmir (R), who sponsored the state senate version of the bill, said allowing such substitutions at the pharmacy level could save consumers as much as 20 percent. Read More
The Prescription Interdiction and Litigation Task Force is looking at existing lawsuits against opioid manufacturers by state and local governments to offer federal assistance where possible. Read More
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee is requesting that sponsors of antiretrovirals submit, by May 8, supplementary safety information related to the risk of autoimmune hepatitis. Read More
Wisconsin and West Virginia passed laws allowing pharmacists to substitute interchangeable biosimilars, bringing the total number of states with such laws to 40. Read More
Three senators wrote to Tri-Source Pharma demanding an explanation for dramatic price spikes for the company’s off-patent cancer drug lomustine. Read More
The Chinese government adopted a major reshuffling of its cabinet departments late last month, including restructuring the State Food and Drug Administration under the authority of a new umbrella agency, the State Market Regulatory Administration. Read More
The research showed that a substantial proportion of off-patent drugs could have additional manufacturers if a system of reciprocal approval were developed. Read More